Image from Fluxergy's factory floor courtesy of Fluxergy
The company’s longer-term goal is to develop the platform to provide “multiple points of information from a single test,” says President Tej Patel.
Fluxergy, a company that has already made headlines for earning a CE mark for its one-hour COVID-19 RT-PCR test, has expanded its U.S. headquarters after commercializing the test globally. The expansion will enable the company to ramp up production of the rapid test as well as further develop the test platform for other uses.
The new 30,000-sq-m facility, located at 15 Musick in Irvine, CA, is essentially across the street from Fluxergy’s existing buildings and will feature the company’s modular approach to in-house manufacturing. When fully operational, the facility is expected to produce one million COVID-19 test kits per month for distribution in Europe, the Middle East, Africa, and Taiwan.